• 时尚资讯
  • 九块邮
  • 手机版
    • 最新折扣
    • 好券直播
    • 品牌券
    • 20封顶
    • 更多导航
      热门活动热门标签
    积分商城
    • 全部>“Litigation” 共262个商品
      • 默认
      • 销量
      • 价格
    • 预订 TAFINLAR (dabrafenib mesylate) Drug Profile, 2025: TAFINLAR (dabrafenib mesylate) drug patents, litigation, SPCs, c

      dabrafenibTAFINLARmesylateDrug

      预订 TAFINLAR (dabrafenib mesylate) Drug Profile, 2025: TAFINLAR (dabrafenib mesylate) drug patents, litigation, SPCs, c

      ¥3,042券后¥3,3420人已购买
      优惠券¥300 领券购买 
    • 预订 Section 1983 Litigation in a Nutshell: 9798887865126

      9798887865126Litigation预订Nutshell

      预订 Section 1983 Litigation in a Nutshell: 9798887865126

      ¥689券后¥7790人已购买
      优惠券¥90 领券购买 
    • 预订 Evidence in International Litigation 国际诉讼的证据: 9789004144491

      International9789004144491诉讼Litigation

      预订 Evidence in International Litigation 国际诉讼的证据: 9789004144491

      ¥2,452券后¥2,7520人已购买
      优惠券¥300 领券购买 
    • 预订 TRINTELLIX (vortioxetine hydrobromide) Drug Profile, 2025: drug patents, patent challenges, litigation, SPCs, clini

      DrugvortioxetinehydrobromideTRINTELLIX

      预订 TRINTELLIX (vortioxetine hydrobromide) Drug Profile, 2025: drug patents, patent challenges, litigation, SPCs, clini

      ¥3,030券后¥3,3300人已购买
      优惠券¥300 领券购买 
    • 预订 CABOMETYX (cabozantinib s-malate) Drug Profile, 2025: CABOMETYX (cabozantinib s-malate) drug patents, litigation, P

      cabozantinibCABOMETYXmalateDrug

      预订 CABOMETYX (cabozantinib s-malate) Drug Profile, 2025: CABOMETYX (cabozantinib s-malate) drug patents, litigation, P

      ¥3,081券后¥3,3810人已购买
      优惠券¥300 领券购买 
    • 预订 CAPLYTA (lumateperone tosylate) Drug Profile, 2025: CAPLYTA (lumateperone tosylate) drug patents, litigation, clini

      lumateperonetosylateCAPLYTADrug

      预订 CAPLYTA (lumateperone tosylate) Drug Profile, 2025: CAPLYTA (lumateperone tosylate) drug patents, litigation, clini

      ¥3,057券后¥3,3570人已购买
      优惠券¥300 领券购买 
    • 预订 VIBERZI (eluxadoline) Drug Profile, 2025: VIBERZI (eluxadoline) drug patents, litigation, SPCs, clinical trials, dr

      eluxadolineVIBERZIDruglitigation

      预订 VIBERZI (eluxadoline) Drug Profile, 2025: VIBERZI (eluxadoline) drug patents, litigation, SPCs, clinical trials, dr

      ¥3,031券后¥3,3310人已购买
      优惠券¥300 领券购买 
    • 预订 BIJUVA (estradiol; progesterone) Drug Profile, 2025: BIJUVA (estradiol; progesterone) drug patents, litigation, SPC

      progesteroneestradiolBIJUVADrug

      预订 BIJUVA (estradiol; progesterone) Drug Profile, 2025: BIJUVA (estradiol; progesterone) drug patents, litigation, SPC

      ¥3,024券后¥3,3240人已购买
      优惠券¥300 领券购买 
    • 预订 Fundamental Pretrial Advocacy: A Strategic Guide to Effective Litigation, 2d Rose和Underwood的基础审前审议:有效诉

      审议FundamentalLitigationStrategic

      预订 Fundamental Pretrial Advocacy: A Strategic Guide to Effective Litigation, 2d Rose和Underwood的基础审前审议:有效诉

      ¥1,695券后¥1,8750人已购买
      优惠券¥180 领券购买 
    • 预订 AURYXIA (ferric citrate) Drug Profile, 2025: AURYXIA (ferric citrate) drug patents, litigation, clinical trials, dr

      AURYXIAcitrateferricDrug

      预订 AURYXIA (ferric citrate) Drug Profile, 2025: AURYXIA (ferric citrate) drug patents, litigation, clinical trials, dr

      ¥3,020券后¥3,3200人已购买
      优惠券¥300 领券购买 
    • 预订 FARXIGA (dapagliflozin) Drug Profile, 2025: FARXIGA (dapagliflozin) drug patents, litigation, PTAB cases, SPCs, cli

      dapagliflozinFARXIGADruglitigation

      预订 FARXIGA (dapagliflozin) Drug Profile, 2025: FARXIGA (dapagliflozin) drug patents, litigation, PTAB cases, SPCs, cli

      ¥3,049券后¥3,3490人已购买
      优惠券¥300 领券购买 
    • 预订 Insurance Rate Litigation

      LitigationInsurance预订Rate

      预订 Insurance Rate Litigation

      ¥1,989券后¥2,2890人已购买
      优惠券¥300 领券购买 
    • 预订 Federal Habeas Corpus: Executive Detention and Post-Conviction Litigation: 9781684678662

      9781684678662LitigationConvictionExecutive

      预订 Federal Habeas Corpus: Executive Detention and Post-Conviction Litigation: 9781684678662

      ¥3,345券后¥3,6450人已购买
      优惠券¥300 领券购买 
    • 预订 The Law of Class Actions and Other Aggregate Litigation: 9781684671311

      9781684671311LitigationAggregate预订

      预订 The Law of Class Actions and Other Aggregate Litigation: 9781684671311

      ¥3,014券后¥3,3140人已购买
      优惠券¥300 领券购买 
    • 预订 Climate Change Litigation: Global Perspectives 气候变化的诉讼:全球视角: 9789004447608

      9789004447608Perspectives视角诉讼

      预订 Climate Change Litigation: Global Perspectives 气候变化的诉讼:全球视角: 9789004447608

      ¥3,604券后¥3,9040人已购买
      优惠券¥300 领券购买 
    • 预订 Back to Court: A Complete Guide to Child Custody Litigation: A Complete Guide to Child Custody Litigation 重返法庭

      LitigationCompleteCustodyGuide

      预订 Back to Court: A Complete Guide to Child Custody Litigation: A Complete Guide to Child Custody Litigation 重返法庭

      ¥138券后¥1480人已购买
      优惠券¥10 领券购买 
    • 预订 Prosecuting and Defending Domain Name Disputes: Effective Litigation Strategies 域名争议的起诉和辩护: 9781035315024

      辩护9781035315024起诉Prosecuting

      预订 Prosecuting and Defending Domain Name Disputes: Effective Litigation Strategies 域名争议的起诉和辩护: 9781035315024

      ¥1,960券后¥2,2600人已购买
      优惠券¥300 领券购买 
    • 预订 A Practical Guide to Cyber Fraud Litigation - Second Edition: 9781914608889

      9781914608889LitigationPractical预订

      预订 A Practical Guide to Cyber Fraud Litigation - Second Edition: 9781914608889

      ¥1,346券后¥1,5260人已购买
      优惠券¥180 领券购买 
    • 【预订】Litigation in Otolaryngology 9783030644208

      Otolaryngology9783030644208Litigation预订

      【预订】Litigation in Otolaryngology 9783030644208

      ¥1,025券后¥1,2050人已购买
      优惠券¥180 领券购买 
    • 预订 VYNDAQEL (tafamidis meglumine) Drug Profile, 2025: VYNDAQEL (tafamidis meglumine) drug patents, litigation, SPCs, c

      tafamidismeglumineVYNDAQELDrug

      预订 VYNDAQEL (tafamidis meglumine) Drug Profile, 2025: VYNDAQEL (tafamidis meglumine) drug patents, litigation, SPCs, c

      ¥3,015券后¥3,3150人已购买
      优惠券¥300 领券购买 
    • 预订 EXPAREL (bupivacaine) Drug Profile, 2025: EXPAREL (bupivacaine) drug patents, litigation, clinical trials, drug pri

      bupivacaineDrugEXPARELlitigation

      预订 EXPAREL (bupivacaine) Drug Profile, 2025: EXPAREL (bupivacaine) drug patents, litigation, clinical trials, drug pri

      ¥3,088券后¥3,3880人已购买
      优惠券¥300 领券购买 
    • 预订 COMETRIQ (cabozantinib s-malate) Drug Profile, 2025: COMETRIQ (cabozantinib s-malate) drug patents, litigation, PTA

      cabozantinibCOMETRIQmalateDrug

      预订 COMETRIQ (cabozantinib s-malate) Drug Profile, 2025: COMETRIQ (cabozantinib s-malate) drug patents, litigation, PTA

      ¥3,066券后¥3,3660人已购买
      优惠券¥300 领券购买 
    • 预订 ENTRESTO (sacubitril; valsartan) Drug Profile, 2025: ENTRESTO (sacubitril; valsartan) drug patents, litigation, PTA

      sacubitrilvalsartanENTRESTODrug

      预订 ENTRESTO (sacubitril; valsartan) Drug Profile, 2025: ENTRESTO (sacubitril; valsartan) drug patents, litigation, PTA

      ¥3,030券后¥3,3300人已购买
      优惠券¥300 领券购买 
    • 预订 TRULANCE (plecanatide) Drug Profile, 2025: TRULANCE (plecanatide) drug patents, litigation, PTAB cases, clinical tr

      plecanatideTRULANCEDruglitigation

      预订 TRULANCE (plecanatide) Drug Profile, 2025: TRULANCE (plecanatide) drug patents, litigation, PTAB cases, clinical tr

      ¥3,018券后¥3,3180人已购买
      优惠券¥300 领券购买 
    • 预订 UBRELVY (ubrogepant) Drug Profile, 2025: UBRELVY (ubrogepant) drug patents, litigation, SPCs, clinical trials, drug

      ubrogepantDrugUBRELVYlitigation

      预订 UBRELVY (ubrogepant) Drug Profile, 2025: UBRELVY (ubrogepant) drug patents, litigation, SPCs, clinical trials, drug

      ¥3,018券后¥3,3180人已购买
      优惠券¥300 领券购买 
    • 预订 STIVARGA (regorafenib) Drug Profile, 2025: STIVARGA (regorafenib) drug patents, patent challenges, litigation, PTAB

      regorafenibSTIVARGADrugchallenges

      预订 STIVARGA (regorafenib) Drug Profile, 2025: STIVARGA (regorafenib) drug patents, patent challenges, litigation, PTAB

      ¥3,065券后¥3,3650人已购买
      优惠券¥300 领券购买 
    • 预订 EDARBI (azilsartan kamedoxomil) Drug Profile, 2025: EDARBI (azilsartan kamedoxomil) drug patents, litigation, SPCs,

      kamedoxomilazilsartanEDARBIDrug

      预订 EDARBI (azilsartan kamedoxomil) Drug Profile, 2025: EDARBI (azilsartan kamedoxomil) drug patents, litigation, SPCs,

      ¥3,044券后¥3,3440人已购买
      优惠券¥300 领券购买 
    • 预订 Systems Implementation Litigation: A Guide for Systems Implementers, Their Customers and the Lawyers Who Represent

      SystemsImplementationImplementersLitigation

      预订 Systems Implementation Litigation: A Guide for Systems Implementers, Their Customers and the Lawyers Who Represent

      ¥433券后¥4930人已购买
      优惠券¥60 领券购买 
    • 预订 VENCLEXTA (venetoclax) Drug Profile, 2025: VENCLEXTA (venetoclax) drug patents, litigation, PTAB cases, SPCs, clini

      venetoclaxVENCLEXTADruglitigation

      预订 VENCLEXTA (venetoclax) Drug Profile, 2025: VENCLEXTA (venetoclax) drug patents, litigation, PTAB cases, SPCs, clini

      ¥3,126券后¥3,4260人已购买
      优惠券¥300 领券购买 
    • 预订 XENLETA (lefamulin acetate) Drug Profile, 2025: XENLETA (lefamulin acetate) drug patents, litigation, SPCs, clinica

      lefamulinXENLETAacetateDrug

      预订 XENLETA (lefamulin acetate) Drug Profile, 2025: XENLETA (lefamulin acetate) drug patents, litigation, SPCs, clinica

      ¥3,015券后¥3,3150人已购买
      优惠券¥300 领券购买 
    • 预订 AMVUTTRA (vutrisiran sodium) Drug Profile, 2025: AMVUTTRA (vutrisiran sodium) drug patents, litigation, SPCs, suppl

      vutrisiranAMVUTTRAsodiumDrug

      预订 AMVUTTRA (vutrisiran sodium) Drug Profile, 2025: AMVUTTRA (vutrisiran sodium) drug patents, litigation, SPCs, suppl

      ¥3,012券后¥3,3120人已购买
      优惠券¥300 领券购买 
    • 预订 Becoming an Expert Witness in Health Care and Litigation: A Beginner’s Guide 成为*保健与诉讼的专家证人:初学者

      证人初学者诉讼Litigation

      预订 Becoming an Expert Witness in Health Care and Litigation: A Beginner’s Guide 成为*保健与诉讼的专家证人:初学者

      ¥1,734券后¥2,0340人已购买
      优惠券¥300 领券购买 
    • 预订 EXONDYS 51 (eteplirsen) Drug Profile, 2025: EXONDYS 51 (eteplirsen) drug patents, litigation, PTAB cases, clinical

      eteplirsenEXONDYSDruglitigation

      预订 EXONDYS 51 (eteplirsen) Drug Profile, 2025: EXONDYS 51 (eteplirsen) drug patents, litigation, PTAB cases, clinical

      ¥3,006券后¥3,3060人已购买
      优惠券¥300 领券购买 
    • 预订 Pretrial Litigation: Law, Policy, and Practice: 9781647084660

      9781647084660Litigation预订Pretrial

      预订 Pretrial Litigation: Law, Policy, and Practice: 9781647084660

      ¥2,866券后¥3,1660人已购买
      优惠券¥300 领券购买 
    • 预订 Securities Litigation, Enforcement, and Compliance: Cases and Materials: 9781647083571

      9781647083571EnforcementSecuritiesLitigation

      预订 Securities Litigation, Enforcement, and Compliance: Cases and Materials: 9781647083571

      ¥3,488券后¥3,7880人已购买
      优惠券¥300 领券购买 
    • 预订 Alternatives to Litigation Mediation, Arbitration, and the Art of Dispute Resolution: Third Edition (NITA) 诉讼调解

      调解AlternativesArbitration诉讼

      预订 Alternatives to Litigation Mediation, Arbitration, and the Art of Dispute Resolution: Third Edition (NITA) 诉讼调解

      ¥1,819券后¥2,1190人已购买
      优惠券¥300 领券购买 
    • 预订 Transnational Civil Litigation: 9781684676187

      Transnational9781684676187Litigation预订

      预订 Transnational Civil Litigation: 9781684676187

      ¥3,345券后¥3,6450人已购买
      优惠券¥300 领券购买 
    • 预订 Civil Litigation: Pretrial Case Development and Discovery: 9781647084752

      9781647084752DevelopmentLitigationDiscovery

      预订 Civil Litigation: Pretrial Case Development and Discovery: 9781647084752

      ¥1,403券后¥1,5830人已购买
      优惠券¥180 领券购买 
    • 预订 QBREXZA (glycopyrronium tosylate) Drug Profile, 2025: QBREXZA (glycopyrronium tosylate) drug patents, litigation, S

      glycopyrroniumtosylateQBREXZADrug

      预订 QBREXZA (glycopyrronium tosylate) Drug Profile, 2025: QBREXZA (glycopyrronium tosylate) drug patents, litigation, S

      ¥3,005券后¥3,3050人已购买
      优惠券¥300 领券购买 
    • 预订 BAXDELA (delafloxacin meglumine) Drug Profile, 2025: BAXDELA (delafloxacin meglumine) drug patents, litigation, SPC

      delafloxacinmeglumineBAXDELADrug

      预订 BAXDELA (delafloxacin meglumine) Drug Profile, 2025: BAXDELA (delafloxacin meglumine) drug patents, litigation, SPC

      ¥3,022券后¥3,3220人已购买
      优惠券¥300 领券购买 
    上一页 1 ...  3   4  5  6   7  下一页